Ignite Creation Date:
2024-10-25 @ 7:47 PM
Last Modification Date:
2024-10-26 @ 3:40 PM
Study NCT ID:
NCT06598527
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-09-14
Brief Title:
Stereotactic Body Radiotherapy Followed by Tislelizumab Plus Platinum-based Chemotherapy Versus Tislelizumav Plus Platinum-based Chemotherapy As Neoadjuvant Therapy in Patients with Resectable Stage Ⅱ-Ⅲ Non-small Cell Lung Cancer a Phase Ⅲ Randomized Multicenter Prospective Study
Sponsor:
Organization:
None